Podocan Is Expressed in Blood and Adipose Tissue and Correlates Negatively With the Induction of Diabetic Nephropathy.

Nio, Yasunori; Okawara, Mitsugi; Okuda, Shoki; Matsuo, Takanori; Furuyama, Naoki

Nio, Yasunori; Okawara, Mitsugi; Okuda, Shoki; Matsuo, Takanori; Furuyama, Naoki.

Afiliación

Nio Y; Extra Value Generation and General Medicine Drug Discovery Unit, Fujisawa, Kanagawa 251-8555, Japan.
Okawara M; Extra Value Generation and General Medicine Drug Discovery Unit, Fujisawa, Kanagawa 251-8555, Japan.
Okuda S; Cardiovascular and Metabolic Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
Matsuo T; Extra Value Generation and General Medicine Drug Discovery Unit, Fujisawa, Kanagawa 251-8555, Japan.
Furuyama N; Japan Medical Affairs, Japan Pharma Business Unit, Takeda Pharmaceutical Company Limited, Chuo-ku, Tokyo 103-8686, Japan.

J Endocr Soc ; 1(7): 772-786, 2017 Jul 01.

Article en En | MEDLINE | ID: mdl-29264529

Palabras clave

adipose tissue; diabetic nephropathy; podocan

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Endocr Soc Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google